Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson (NYSE:JNJ), filed a Form 4 on August 14, 2026, reporting stock option exercises and open-market sales of common stock transacted on August 13, 2026.

Key Highlights

  • Option exercise: Duato exercised 123,291 employee stock options at a conversion price of $115.67, acquiring 123,291 shares of common stock on August 13, 2026.
  • Open-market sales: 20,976 shares were sold at $262 per share and 102,315 shares were sold at $261 per share on August 13, 2026.
  • Direct ownership following transactions: Duato directly held 275,967 shares of common stock after the reported transactions.
  • Indirect holdings: An additional 1,018 shares are held indirectly through a 401(k) plan and 30,852 shares are held indirectly by spouse, according to the filing.
  • Options fully exercised: Following the exercise, zero employee stock options remain beneficially owned directly, the filing states.
  • Signed by attorney-in-fact: The form was signed by Joleen Morgan as attorney-in-fact for Joaquin Duato on August 14, 2026.

Details of Duato's August 2026 Stock Transactions at Johnson & Johnson

According to the filing, Duato exercised 123,291 employee stock options on August 13, 2026, at an exercise price of $115.67 per share, classified under transaction code "M." The filing notes these options were awarded under the issuer's Long-Term Incentive Plan, became exercisable on February 14, 2020, and carry an expiration date of February 13, 2027. The filing describes the options as vesting and becoming exercisable on the third anniversary of the grant date.

On the same date, the filing reports two separate dispositions of common stock. Duato sold 20,976 shares at $262 per share and 102,315 shares at $261 per share, both classified under transaction code "S." Following all three transactions, his directly held common stock position stood at 275,967 shares, according to the filing.

The filing also discloses indirect beneficial ownership of 1,018 shares held through the Johnson & Johnson Savings Plan's Johnson & Johnson Stock Fund, with a footnote stating these include shares accrued through dividend reinvestment as of the plan's most recent reporting date of 6/31/2026. An additional 30,852 shares are reported as held indirectly by Duato's spouse. After the option exercise, no employee stock options remain directly held, the filing states.

What Was Disclosed

The filing discloses that Johnson & Johnson CEO and Chairman Joaquin Duato exercised 123,291 stock options and sold a combined 123,291 shares of common stock on August 13, 2026, leaving him with 275,967 directly held shares plus additional indirect holdings.